Skip to content
DataLookout
Menu

NCT06275724

Specified Drug-use Survey of Leqvio for s.c. Injection.

StatusCompleted
PhaseNot specified
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 15 versions: 13 with changes below, 2 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 5 words
    • Trial completed
    • Primary completion date changed from estimate of Dec 17, 2026 to Nov 1, 2026
    • Site details revised at 80 of 107 sites
  2. Minor Site details revised at 1 of 107 sitesv14
  3. Minor Study sites: 106 to 107v11
  4. Minor Study sites: 107 to 106v10
  5. Notable Primary and study completion dates: Dec 31, 2027 to Dec 17, 2026
    • Enrollment target: 583 to 585
    • Site details revised at 96 of 107 sites
    v9
Show 7 earlier versionsHide 7 earlier versions
  1. Minor Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 560 to confirmed 583
    • Site details revised at 107 of 107 sites
    v8
  2. Minor Study sites: 100 to 107v7
  3. Minor Study sites: 88 to 100v6
  4. Minor Study sites: 75 to 88v5
  5. Minor Study sites: 66 to 75v4
  6. Minor Study sites: 26 to 66v3
  7. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 26
    • Primary and study completion dates: Feb 28, 2028 to Dec 31, 2027
    • Start date changed from estimate of Mar 31, 2024 to Mar 4, 2024
    v2
  1. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Number of patients with adverse events
Timeframe: Up to 24 months
Numbers of patients with serious adverse events, adverse events by severity, and adverse drug reactions
Timeframe: Up to 24 months

Secondary (2)

Number of patients with adverse events leading to discontinuation of treatment with the product
Percent change from baseline in LDL-C levels

Arms and interventions

inclisiran

Patients prescribed with inclisiran

Other: inclisiran

Sites

107 sites in 1 country